Sartorius rises after Berenberg upgrade

Sartorius AG

27/04/2026 08:27

** Shares of Sartorius SRT3.DE up as much as 4.4% after Berenberg upgrades the German biopharma equipment supplier to "buy" from "hold", citing a positive shift in risk-reward after a series of negative consensus revisions

** The broker views the post-Q1-results share price drop as an overreaction, urging investors to "look through the noise" and saying the negative revision cycle has run its course

** "We think this move largely related to a broader rotation out of the life science tools space plus concerns regarding its lack of commitment to double-digit bioprocessing consumables growth in 2026"

** Berenberg points to strong bioprocessing outlooks from peers Danaher DHR.N and Thermo Fisher TMO.N as indications that double-digit growth is possible

** "There has been an acceleration in high-premium biopharma M&A and improved biotech funding," the broker adds

** Sartorius is one of the top gainer of the German mid-cap index .MDAXI

 (Reporting by Simon Ferdinand Eibach)

 ((Simonferdinand.eibach@thomsonreuters.com))